With AI-enabled care strategies and digital technologies, clinicians and patients are embracing new approaches to improve the lives of cancer patients through enhanced diagnosis and treatment. These include AI-guided tools for more precise methods of predicting risk, more effective screening strategies, patient data driven insights and more personalized treatments. Panelists will engage on how these and other innovations are enabling a new era of cancer care.
Moderator: Constance Lehman, MD, PhD, Chief, Breast Imaging Division, MGH; Professor of Radiology, HMS
Dawn Barry, President and Co-Founder, LunaDNA
Regina Barzilay, PhD, Delta Electronics Professor, Electrical Engineering and Computer Science Department, MIT
Gad Getz, PhD, Director, Cancer Genome Analysis, Broad Institute; Professor, Pathology, HMS
Daphne Koller, PhD, CEO, insitro
